Neurointerventional Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Neurointerventional Devices Market is segmented By Product, By Application (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Diseases), and Geography.

Neurointerventional Devices Market Snapshot

Neurointerventional Devices Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >7.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The neurointerventional devices are used by medical professionals specialized in the domain of central nervous system (CNS). It is usually practised by neuroradiologists, neurosurgeons and neurologists exploring the endovascular approach to treat the vascular diseases of the CNS. A wide range of vascular diseases burden associated with the CNS primarily drives the usage of devices. As per the American Association of Neurological Surgeons, Stroke is the third leading cause of death in the United States. About 700,000 are affected each year of which, 200,000 are the recurrent attacks cases. The consistent high volume of patients with vascular diseases approaching the healthcare facilities, increases the demand of the neurointerventional devices in a region. The direct and indirect high cost of the devices and procedure as well as stringent regulations are some of primary limitations to the growth of the studied market.

Scope of the Report

Neurointerventional devices are primarily linked to treatment of diseases with vascular diseases in the CNS. The market is segmented by product, by application and by geography.

By Product
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Neurothrombectomy Devices
Other Devices
By Application
Ischemic Stroke
Cerebral Aneurysms
Arteriovenous Malformation and Fistulas
Other Diseases
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Treatment of Ischemic Stroke is Expected to Hold Major Share of the Market Over the Forecast Period

  • Ischemic stroke refers to the blockade of an artery in the brain. It accounts to about 87% of all the strokes, therefore, is of primary concerns to the medical professional associated with the treatment of CNS diseases.
  • The revascularization devices are a common solution of the treatment of such injuries. The Solitaire™ X Revascularization Device by the Medtronic PLC, is indicated to restore the blood flow from a large intracranial vessel in patients experiencing ischemic stroke.
  • With wide range of applications linked to the arterial based diseases correction, there is significant usage of the neurointerventional devices. Thus, across all kind of diseases linked to CNS, the demand for neurinterventional devices is expected to steadily grow over the forecast period.
Neurointerventional Devices Market

North America is Expected to Hold a Significant Share in the Market with Similar Trend in the Forecast Period

North America with its advanced healthcare infrastructure across majority of places, and presence of many medical devices companies well-connected with the hospitals primarily boost the growth  of this market. In the United States, it is estimated that atleast one stroke within every 40 seconds occurs and every four minutes, someone dies of a stroke. Approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Similarly, as per stated by the Brain Aneurysm Foundation, cerebral aneurysms affect an estimated 6 million Americans and are accountable for nearly half a million deaths worldwide each year, with half the victims age 50 and younger. The presence of several foundations which acts support systems for many healthcare providers associated with the treatment of CNS vascular diseases also fuels the use of neurointerventional devices market.

Neurointerventional Devices Market

Competitive Landscape

The companies have identified consistent growth opportunities in the treatment of endovascular based diseases via neurostimulation devices. Some of the major companies in this segment include Abbott Laboratories, Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker, Penumbra, Inc., and others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Target Patient Population

      2. 4.2.2 Ongoing Product Development and Commercialization

      3. 4.2.3 Rising Research Activities in the Field of Neurovascular Therapies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Dearth of Skilled Neurosurgeons

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Aneurysm Coiling & Embolization Devices

      2. 5.1.2 Cerebral Balloon Angioplasty and Stenting Systems

      3. 5.1.3 Neurothrombectomy Devices

      4. 5.1.4 Other Devices

    2. 5.2 By Application

      1. 5.2.1 Ischemic Stroke

      2. 5.2.2 Cerebral Aneurysms

      3. 5.2.3 Arteriovenous Malformation and Fistulas

      4. 5.2.4 Other Diseases

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Johnson & Johnson (DePuy Synthes)

      3. 6.1.3 Medtronic plc

      4. 6.1.4 MicroPort Scientific Corporation

      5. 6.1.5 Penumbra, Inc.

      6. 6.1.6 Stryker

      7. 6.1.7 Terumo Corporation

      8. 6.1.8 W. L. Gore & Associates, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Neurointerventional Devices Market market is studied from 2018 - 2026.

The Neurointerventional Devices Market is growing at a CAGR of >7.7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories , Johnson & Johnson (DePuy Synthes) , Medtronic PLC , Stryker , Penumbra, Inc. are the major companies operating in Neurointerventional Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!